LY96 and metabolic dysfunction-associated steatotic liver disease: In human studies, liver tissues of subjects with NAFLD activity (GSE151158,21 GSE6306722 and GSE12684823) showed elevated levels of Md2 mRNA compared to health/NALFD‐activity‐negative samples (Figure 1A).